Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis [NA]

View source ↗

Summary

A clinical trial update indicates Sirt3 LLC is sponsoring a study to evaluate Magnolia officinalis dietary supplement on immune biomarkers in subjects with psor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnolia officinalis dietary supplement (Magnolia officinalis extract)

Snippet

Sponsor: Sirt3 LLC | Conditions: Psoriasis | NA | Status: RECRUITING